Overview
Ippokratis Messaritakis practices in Athens, Greece. Messaritakis is rated as a Distinguished expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Their top areas of expertise are Small Cell Lung Cancer (SCLC), Colorectal Cancer, Lung Cancer, and Familial Colorectal Cancer.
Their clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Small Cell Lung Cancer (SCLC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Small Cell Lung Cancer (SCLC)Messaritakis isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Colorectal CancerMessaritakis isAdvanced. Learn about Colorectal Cancer.
- Lung CancerMessaritakis isAdvanced. Learn about Lung Cancer.
- Experienced
- AnemiaMessaritakis isExperienced. Learn about Anemia.
- Familial Colorectal CancerMessaritakis isExperienced. Learn about Familial Colorectal Cancer.
- Febrile NeutropeniaMessaritakis isExperienced. Learn about Febrile Neutropenia.
- LeishmaniasisMessaritakis isExperienced. Learn about Leishmaniasis.
- Lung MetastasesMessaritakis isExperienced. Learn about Lung Metastases.
- Non-Small Cell Lung Cancer (NSCLC)Messaritakis isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).